<?xml version="1.0" encoding="UTF-8"?>
<p>Laboratory evidence of ZIKV infection can be obtained by testing clinical samples (biofluids and tissue) for viral nucleic acid or virus-specific IgM and IgG antibodies [
 <xref rid="B12-tropicalmed-05-00097" ref-type="bibr">12</xref>]. Serologic testing is recommended in individuals if the specimen is collected more than 1 week after the onset of symptoms [
 <xref rid="B13-tropicalmed-05-00097" ref-type="bibr">13</xref>]. Due to the clinical manifestations and the associated consequences, diagnostic requests in those countries at the highest risk of a ZIKV outbreak are forecast to increase substantially [
 <xref rid="B14-tropicalmed-05-00097" ref-type="bibr">14</xref>]. The ZIKV shares a considerable degree of structural homology with other flaviviruses [
 <xref rid="B15-tropicalmed-05-00097" ref-type="bibr">15</xref>,
 <xref rid="B16-tropicalmed-05-00097" ref-type="bibr">16</xref>]. Serology-based diagnosis has historically posed a challenge due to the well-known problem of potential cross-reactivity with antibodies produced, particularly against other flaviviruses including DENV [
 <xref rid="B12-tropicalmed-05-00097" ref-type="bibr">12</xref>].
</p>
